Esophageal candidiasis medical therapy: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(3 intermediate revisions by 2 users not shown)
Line 27: Line 27:
===HIV patients:===
===HIV patients:===
*[[HIV AIDS medical therapy|Highly active antiretroviral theapy (HAART)]] decreases recurrence of candida esophagitis.
*[[HIV AIDS medical therapy|Highly active antiretroviral theapy (HAART)]] decreases recurrence of candida esophagitis.
=== Supportive therapy in patients with severe odynophagia: ===
==== Nutritional support: ====
* [[IV fluids]] or [[TPN|total parentral nutrition]].
* Gastric tube feeding
==== Symptomatic treatment: ====
* [[Analgesics]] in the form of [[NSAIDs]] or [[morphia]].
* [[Calcium channel blocker|Calcium channel blockers]] to avoid spasms in response to the pain.


==References==
==References==
{{Reflist|2}}
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Gastroenterology]]
[[Category:Otolaryngology]]
[[Category:Immunology]]

Latest revision as of 21:40, 29 July 2020

Esophageal candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal candidiasis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal candidiasis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal candidiasis medical therapy

CDC on Esophageal candidiasis medical therapy

Esophageal candidiasis medical therapy in the news

Blogs on Esophageal candidiasis medical therapy

Directions to Hospitals Treating Esophageal candidiasis

Risk calculators and risk factors for Esophageal candidiasis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Esophageal candidiasis is almost always treated with systemic antifungals (either parentral or oral). A trial of antifungal therapy is done before performing endoscopy in HIV patients with esophagitis.

Medical therapy

First line antifungal therapy:

In fluconazole refractory patients:

Prophylactic (suppressive) therapy:

HIV patients:

Supportive therapy in patients with severe odynophagia:

Nutritional support:

Symptomatic treatment:

References

  1. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016). "Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America". Clin. Infect. Dis. 62 (4): e1–50. doi:10.1093/cid/civ933. PMC 4725385. PMID 26679628.